Journal
CANCER CELL
Volume 12, Issue 6, Pages 559-571Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2007.11.004
Keywords
-
Categories
Funding
- NCI NIH HHS [U01-CA84296, P50CA058204, U01 CA084296] Funding Source: Medline
- NIGMS NIH HHS [R25 GM056929, 1F31-GM069044] Funding Source: Medline
Ask authors/readers for more resources
Fibroblast Growth Factor Receptor-1 (FGFR1) is commonly overexpressed in advanced prostate cancer (PCa). To investigate causality, we utilized an inducible FGFR1 (iFGFR1) prostate mouse model. Activation of iFGFR1 with chemical inducers of dimerization (CID) led to highly synchronous, step-wise progression to adenocarcinoma that is linked to an epithelial-to-mesenchymal transition (EMT). iFGFR1 inactivation by CID withdrawal led to full reversion of prostatic intraepithelial neoplasia, whereas PCa lesions became iFGFR1-independent. Gene expression profiling at distinct stages of tumor progression revealed an increase in EMT-associated Sox9 and changes in the Wnt signaling pathway, including Fzd4, which was validated in human PCa. The iFGFR1 model clearly implicates FGFR1 in PCa progression and demonstrates how CID-inducible models can help evaluate candidate molecules in tumor progression and maintenance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available